Pandora A/S
9.2.2026 14:00:42 CET | Globenewswire | Press release
Major shareholder announcement
Major shareholder announcement
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that BlackRock, Inc. has notified the company that it now holds 6,729,003 shares, corresponding to 8.51% of the total voting rights and share capital (unchanged). Additionally, BlackRock, Inc. controls voting rights attached to financial instruments amounting to 1.55% (previously 1.45%). In total, BlackRock, Inc. control 10.07% of the company’s voting rights (previously 9.97%).
ABOUT PANDORA
Pandora is the world's largest jewellery brand, specialising in the design, crafting and marketing of accessible luxury jewellery made from high-quality materials. Each piece is created to inspire self-expression, allowing people to share their stories and passions through meaningful jewellery. Pandora jewellery is sold in more than 100 countries through 7,000 points of sale, including more than 2,800 concept stores.
Headquartered in Copenhagen, Denmark, Pandora employs around 39,000 people worldwide and crafts its jewellery with 100% recycled silver and gold. Pandora is committed to leadership in sustainability and has set out to halve greenhouse gas emissions across its value chain by 2030. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated revenue of DKK 32.5 billion (EUR 4.4 billion) in 2025.
CONTACT
For more information, please contact:
| Investor Relations BILAL AZIZ SVP, Investor Relations & Treasury +45 3137 9486 biazi@pandora.net | Corporate Communications JOHAN MELCHIOR VP, Media Relations & Public Affairs +45 4060 1415 jome@pandora.net |
ADAM FUGLSANG Director, Investor Relations +45 6167 7425 adfug@pandora.net | |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Coloplast A/S18.8.2026 07:30:11 CEST | Press release
Coloplast A/S - Interim Financial Report, 9M 2025/26
Coloplast A/S18.8.2026 07:30:11 CEST | Pressemeddelelse
Coloplast A/S - Regnskabsmeddelelse, 9M 2025/26
Basilea Pharmaceutica International Ltd, Allschwil18.8.2026 07:15:00 CEST | Press release
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
dsm-firmenich18.8.2026 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
dsm-firmenich18.8.2026 07:00:00 CEST | Press release
dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen’s decision to retire
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom